Bristol-Myers Squibb second-one fourth net sales increase 2 percent to $4.

Bristol-Myers Squibb second-one fourth net sales increase 2 percent to $4 questions et rĂ©ponses .8 billion Bristol-Myers Squibb Organization today reported results for the second one fourth of 2010 which featured data on important marketed and investigational compounds in its oncology, diabetes and cardiovascular franchises, and development in EPS and product sales. The business also confirmed guidance for 2010 2010 and minimum guidance for non-GAAP EPS in 2013. ‘Our second quarter performance proceeds to strengthen our self-confidence in our capability to execute the main element elements of our differentiated and concentrated BioPharma strategy.

Other entries from category "gear":

Random entries